CSIMarket Company Name, Ticker, Competitors, else..
 
I mab  (NASDAQ: IMAB)
Other Ticker:  
 
 
Price: $0.8485 $0.02 2.180%
Day's High: $0.8998 Week Perf: 26.79 %
Day's Low: $ 0.83 30 Day Perf: -4.56 %
Volume (M): 106 52 Wk High: $ 2.00
Volume (M$): $ 90 52 Wk Avg: $1.22
Open: $0.86 52 Wk Low: $0.60



 Market Capitalization (Millions $) 158
 Shares Outstanding (Millions) 187
 Employees -
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -22
 Cash Flow (TTM) (Millions $) -242
 Capital Exp. (TTM) (Millions $) 0

I Mab
I mab, also known as immunomodulatory antibody, is a type of monoclonal antibody that is used in immunotherapy for the treatment of certain diseases. It acts by targeting specific proteins on cells of the immune system, thereby modulating immune responses. This can be done by either enhancing or suppressing the activity of immune cells, depending on the specific disease being treated. I mab has shown promising results in treating various conditions such as cancer, autoimmune disorders, and inflammatory diseases. It is typically administered intravenously and may be used in combination with other therapies to improve treatment outcomes.


   Company Address: 2440 Research Boulevard, Suite 400 Rockville 20850 MD
   Company Phone Number: 745-6330   Stock Exchange / Ticker: NASDAQ IMAB


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BMY      % 
JNJ      % 
LLY      % 
MRK      % 
REGN        6.13% 
SNY        6.13% 
• View Complete Report
   



Clinical Study

Ragistomig: A Promising PD-L1x4-1BB Bispecific Antibody for Cancer Immunotherapy

Published Thu, May 23 2024 9:05 PM UTC

The field of cancer immunotherapy has seen significant advancements in recent years, with the development of novel immunotherapies that aim to harness the body s immune system to fight against cancer. One such promising immunotherapy is ragistomig, a PD-L1x4-1BB bispecific antibody, developed by I-Mab, a global biotech company. In this article, we will delve into the encoura...









Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com